The framework consists of 2 documents that expand on the agency’s plans for its risk-based approach for describing drugs, devices, and biologics, including those designated as regenerative medicine advanced therapies.
The Director of the Jefferson Headache Center spoke about migraine therapies that hold excitement and promise in the new year.

SAP Partner Banner